These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37767187)

  • 81. Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.
    Yi Y; Lu X; Chen J; Jiao C; Zhong J; Song Z; Yu X; Lin B
    Exp Ther Med; 2016 Nov; 12(5):3411-3416. PubMed ID: 27882172
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
    Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
    Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP.
    Yu F; Lin Y; Tan G; Ai M; Gong H; Liu W; Huang J; Zou Z
    Cell Cycle; 2022 Apr; 21(7):730-740. PubMed ID: 35156506
    [TBL] [Abstract][Full Text] [Related]  

  • 84. PAQR3 modulates insulin signaling by shunting phosphoinositide 3-kinase p110α to the Golgi apparatus.
    Wang X; Wang L; Zhu L; Pan Y; Xiao F; Liu W; Wang Z; Guo F; Liu Y; Thomas WG; Chen Y
    Diabetes; 2013 Feb; 62(2):444-56. PubMed ID: 23086038
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A Comprehensive Study on Signal Transduction and Therapeutic Role of miR-877 in Human Cancers.
    Rafat M; Kohsarian M; Bahiraei M; Nikpoor AR
    Adv Biomed Res; 2023; 12():118. PubMed ID: 37434921
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Circ_0007624 suppresses the development of esophageal squamous cell carcinoma via targeting miR-224-5p/CPEB3 to inactivate the EGFR/PI3K/AKT signaling.
    Cheng J; Ma H; Yan M; Zhang Z; Xing W
    Cell Signal; 2022 Nov; 99():110448. PubMed ID: 35998761
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.
    Yang C; Shen S; Zheng X; Ye K; Sun Y; Lu Y; Ge H
    FASEB J; 2019 Sep; 33(9):10490-10504. PubMed ID: 31311326
    [TBL] [Abstract][Full Text] [Related]  

  • 89. MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β-catenin signaling pathway and EMT in esophageal squamous cell carcinoma.
    Meng J; Zhang C; Zhao T; Shi G; Zhao J; Lin Z
    Thorac Cancer; 2021 Mar; 12(6):932-940. PubMed ID: 33538099
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p.
    Yin X; Wang J; Shan C; Jia Q; Bian Y; Zhang H
    Bioengineered; 2022 Mar; 13(3):6929-6941. PubMed ID: 35236250
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.
    Hou CH; Lin FL; Hou SM; Liu JF
    Mol Cancer; 2014 Oct; 13():236. PubMed ID: 25326651
    [TBL] [Abstract][Full Text] [Related]  

  • 93. METTL14 derived from exosomes of M1 macrophages promotes high glucose-induced apoptosis, inflammation and oxidative stress in glomerular endothelial cells by mediating PAQR3 m6A modification.
    Li Y; Zhang J; Zhu Y
    Clin Exp Nephrol; 2024 Dec; 28(12):1221-1231. PubMed ID: 39080055
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.
    Zhao C; Li Y; Chen G; Wang F; Shen Z; Zhou R
    Oncol Rep; 2017 Jul; 38(1):352-358. PubMed ID: 28560431
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
    Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD
    Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770
    [TBL] [Abstract][Full Text] [Related]  

  • 96. PAQR3: a novel tumor suppressor gene.
    Yu X; Li Z; Chan MT; Wu WK
    Am J Cancer Res; 2015; 5(9):2562-8. PubMed ID: 26609468
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications.
    Guo Q; Liu XL; Zhai K; Chen C; Ke XX; Zhang J; Xu G
    Int J Gen Med; 2023; 16():4321-4328. PubMed ID: 37767187
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN; Hong LL; Wu J; Ling ZQ
    Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.